RxSight Announces Appointments to its Board of Directors
ALISO VIEJO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as of the closing of the Company’s initial public offering on August 3, 2021. The three appointments, including Robert (Bob) Palmisano, Robert Warner and Julie Andrews, joined directors J. Andy Corley, William J. Link, Ph.D., Juliet Tammenoms Bakker and Ron M. Kurtz, M.D. Concurrent with the new appointments, the Company announced the resignations of four long-serving board members Bruce Robertson, Ph.D., Daniel Schwartz, M.D., Christopher Cox, and Rick Wolfen.
“We are excited to welcome Bob, Robert and Julie to the RxSight Board of Directors as we move forward as a public company focused on improving patient vision after cataract surgery....
